{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T22:40:43Z","timestamp":1792363243141,"version":"4.4.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000996","name":"Department of Foreign Affairs and Trade, Australian Government","doi-asserted-by":"publisher","award":["74431"],"award-info":[{"award-number":["74431"]}],"id":[{"id":"10.13039\/501100000996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000996","name":"Department of Foreign Affairs and Trade, Australian Government","doi-asserted-by":"publisher","award":["74431"],"award-info":[{"award-number":["74431"]}],"id":[{"id":"10.13039\/501100000996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000996","name":"Department of Foreign Affairs and Trade, Australian Government","doi-asserted-by":"publisher","award":["74431"],"award-info":[{"award-number":["74431"]}],"id":[{"id":"10.13039\/501100000996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000996","name":"Department of Foreign Affairs and Trade, Australian Government","doi-asserted-by":"publisher","award":["74431"],"award-info":[{"award-number":["74431"]}],"id":[{"id":"10.13039\/501100000996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000996","name":"Department of Foreign Affairs and Trade, Australian Government","doi-asserted-by":"publisher","award":["74431"],"award-info":[{"award-number":["74431"]}],"id":[{"id":"10.13039\/501100000996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000996","name":"Department of Foreign Affairs and Trade, Australian Government","doi-asserted-by":"publisher","award":["74431"],"award-info":[{"award-number":["74431"]}],"id":[{"id":"10.13039\/501100000996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000996","name":"Department of Foreign Affairs and Trade, Australian Government","doi-asserted-by":"publisher","award":["74431"],"award-info":[{"award-number":["74431"]}],"id":[{"id":"10.13039\/501100000996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000996","name":"Department of Foreign Affairs and Trade, Australian Government","doi-asserted-by":"publisher","award":["74431"],"award-info":[{"award-number":["74431"]}],"id":[{"id":"10.13039\/501100000996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2008501"],"award-info":[{"award-number":["2008501"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Papua has a high burden of malaria, with an annual parasite incidence 300 times the national average. A key component of malaria elimination strategies is robust surveillance which is essential for monitoring trends in case numbers, guiding public health interventions, and prioritizing resource allocation. This study aimed to enhance malaria surveillance in Central Papua, Indonesia, by improving data collection, record-keeping, and treatment practices.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The study was conducted at five public clinics in Central Papua province, Indonesia, as part of a wider health systems strengthening programme to promote safer and more effective anti-malarial treatment (The SHEPPI Study). Clinical and laboratory details of patients with malaria and their treatment were documented in clinic registers which were digitalized into an electronic database. Automated reports were generated each month and used to provide regular feedback to clinic staff. Continuous Quality Improvement (CQI) workshops were conducted with clinic staff using the Plan-Do-Study-Act approach to address challenges and drive sustained improvements.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Between January 2019 and December 2023, a total of 314,561 patients were tested for malaria, of whom 41.9% (131,948) had peripheral parasitaemia detected. The first round of Continuous Quality Improvement (CQI) workshops were held in May 2019 and improved data quality significantly, increasing data completeness from 46.3% (4540\/9802) in the initial period (Jan\u2013May 2019) to 71.5% (9053\/12,665) after the first CQI (Jun\u2013Oct 2019), p\u2009&lt; 0.001. The second CQI round reduced DHP prescribing errors from 17.1% (1111\/6489) in the initial period to 5.7% (607\/10,669) after the second CQI (Sep 2019\u2013Jan 2020) and PQ prescribing errors from 17.4% (552\/3175) to 3.4% (160\/4659) over the same time interval, p\u2009&lt; 001. In total, 347 patients were prescribed fewer than the recommended number of PQ tablets during the initial period, 89 (25.6%) of whom were erroneously given only a single dose. Over the 4\u00a0year study period, a total of 11 workshops were conducted, driving continuous improvements in data quality and prescribing practices.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>One or two rounds of CQI, supported by regular follow-up, can enhance the quality of malariometric surveillance, however interventions needed to be tailored to address specific needs of participating clinics. Improvements in data quality and prescribing practices have potential to contribute to better malaria management, improved clinical outcomes, and strengthened trust in healthcare providers.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12936-025-05358-x","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T10:24:40Z","timestamp":1749032680000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Enhanced data quality to improve malaria surveillance in Papua, Indonesia"],"prefix":"10.1186","volume":"24","author":[{"given":"Liony","family":"Fransisca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faustina Helena","family":"Burdam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enny","family":"Kenangalem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annisa","family":"Rahmalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reynold Rizal","family":"Ubra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel H. A.","family":"van den Boogaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Ley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas M.","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne Rini","family":"Poespoprodjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ric N.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"5358_CR1","unstructured":"WHO. World malaria report 2024. Geneva: World Health Organization, 2024. https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2024. Accessed 3 Mar 2025."},{"key":"5358_CR2","first-page":"2021","volume-title":"Global technical strategy for malaria 2016\u20132030, update","author":"WHO","year":"2021","unstructured":"WHO. Global technical strategy for malaria 2016\u20132030, update. 1st ed. Geneva: World Health Organization; 2021. p. 2021.","edition":"1"},{"key":"5358_CR3","unstructured":"WHO. Malaria surveillance, monitoring and evaluation: a reference manual. Geneva: World Health Organization. 2018. https:\/\/iris.who.int\/handle\/10665\/272284. Accessed 15 Oct 2024."},{"issue":"2_Suppl","key":"5358_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4269\/ajtmh.22-0181","volume":"108","author":"A Fountain","year":"2023","unstructured":"Fountain A, Ye Y, Roca-Feltrer A, Rowe AK, Camara A, Fofana A, et al. Surveillance as a core intervention to strengthen malaria control programs in moderate to high transmission settings. Am J Trop Med Hyg. 2023;108(2_Suppl):8\u201313.","journal-title":"Am J Trop Med Hyg"},{"key":"5358_CR5","unstructured":"Indonesian Ministry of Health. Permenkes No. 22 Tahun 2022: Penanggulangan Malaria. Database Peratur. JDIH BPK. http:\/\/peraturan.bpk.go.id\/Details\/245542\/permenkes-no-22-tahun-2022. Accessed 16 Oct 2024."},{"issue":"3 Suppl","key":"5358_CR6","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4269\/ajtmh.14-0834","volume":"93","author":"ML Wilson","year":"2015","unstructured":"Wilson ML, Krogstad DJ, Arinaitwe E, Arevalo-Herrera M, Chery L, Ferreira MU, et al. Urban malaria: understanding its epidemiology, ecology, and transmission across seven diverse ICEMR network sites. Am J Trop Med Hyg. 2015;93(3 Suppl):110\u201323.","journal-title":"Am J Trop Med Hyg"},{"key":"5358_CR7","unstructured":"WHO. Who Do We Leave Behind? Insights on community, human rights, and gender issues in malaria elimination. Geneva, World Health Organization. https:\/\/www.who.int\/indonesia\/news\/detail\/08-06-2023-who-do-we-leave-behind--insights-on-community--human-rights--and-gender-issues-in-malaria-elimination. Accessed 16 Oct 2024."},{"key":"5358_CR8","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1186\/s12936-016-1588-8","volume":"15","author":"M Karyana","year":"2016","unstructured":"Karyana M, Devine A, Kenangalem E, Burdarm L, Poespoprodjo JR, Vemuri R, et al. Treatment-seeking behaviour and associated costs for malaria in Papua, Indonesia. Malar J. 2016;15:536.","journal-title":"Malar J"},{"key":"5358_CR9","unstructured":"National action plan to accelerate malaria elimination 2020\u20132026."},{"key":"5358_CR10","unstructured":"Kegiatan pertemuan koodinasi kelompok kerja diagnosis dan pengobatan malaria kementerian kesehatan tahun 2024. Malaria. https:\/\/malaria.kemkes.go.id\/node\/212. Accessed 3 Mar 2025."},{"key":"5358_CR11","unstructured":"Dinas Kesehatan Kabupaten Mimika. Laporan program malaria Kabupaten Mimika. 2024."},{"key":"5358_CR12","unstructured":"Indonesian Ministry of Health. Pedoman penggunaan elektronik sistem informasi surveilans malaria (E-SISMAL). Google Docs. https:\/\/docs.google.com\/document\/d\/1jiSi1O9_-B3N45CfUweKfby8EIm9HOEvHB8oaZu_4YY\/edit?usp=sharing&usp=embed_facebook. Accessed 16 Oct 2024."},{"key":"5358_CR13","unstructured":"Indonesian Ministry of Health. SISMAL: Syarat dan Ketentuan Sismal V3. https:\/\/sismal.kemkes.go.id\/term-condition. Accessed 16 Oct 2024."},{"issue":"Suppl 6","key":"5358_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4269\/ajtmh.16-0141","volume":"95","author":"RE Howes","year":"2016","unstructured":"Howes RE, Battle KE, Mendis KN, Smith DL, Cibulskis RE, Baird JK, et al. Global epidemiology of Plasmodium vivax. Am J Trop Med Hyg. 2016;95(Suppl 6):15\u201334.","journal-title":"Am J Trop Med Hyg"},{"key":"5358_CR15","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/S1473-3099(14)70855-2","volume":"14","author":"RN Price","year":"2014","unstructured":"Price RN, von Seidlein L, Valecha N, Nosten F, Baird JK, White NJ. Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14:982\u201391.","journal-title":"Lancet Infect Dis"},{"key":"5358_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/infdis\/jiy484","volume":"219","author":"J Popovici","year":"2019","unstructured":"Popovici J, Pierce-Friedrich L, Kim S, Bin S, Run V, Lek D, et al. Recrudescence, reinfection, or relapse? A more rigorous framework to assess chloroquine efficacy for Plasmodium vivax malaria. J Infect Dis. 2019;219:315\u201322.","journal-title":"J Infect Dis"},{"key":"5358_CR17","doi-asserted-by":"publisher","first-page":"4610","DOI":"10.1128\/AAC.00186-16","volume":"60","author":"L Zuluaga-Id\u00e1rraga","year":"2016","unstructured":"Zuluaga-Id\u00e1rraga L, Blair S, Akinyi Okoth S, Udhayakumar V, Marcet PL, Escalante AA, et al. Prospective study of Plasmodium vivax malaria recurrence after radical treatment with a chloroquine-primaquine standard regimen in turbo, colombia. Antimicrob Agents Chemother. 2016;60:4610\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"5358_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s13071-021-04792-5","volume":"14","author":"A Mahittikorn","year":"2021","unstructured":"Mahittikorn A, Masangkay FR, Kotepui KU, Milanez GDJ, Kotepui M. The high risk of malarial recurrence in patients with Plasmodium-mixed infection after treatment with antimalarial drugs: a systematic review and meta-analysis. Parasit Vectors. 2021;14:280.","journal-title":"Parasit Vectors"},{"key":"5358_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12936-019-2644-y","volume":"18","author":"A Daher","year":"2019","unstructured":"Daher A, Silva JCAL, Stevens A, Marchesini P, Fontes CJ, Ter Kuile FO, et al. Evaluation of Plasmodium vivax malaria recurrence in Brazil. Malar J. 2019;18:18.","journal-title":"Malar J"},{"key":"5358_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.su7303a1","volume":"73","author":"SEB Felix","year":"2024","unstructured":"Felix SEB. A standard framework for evaluating large health care data and related resources. MMWR Suppl. 2024;73:1\u201313.","journal-title":"MMWR Suppl"},{"key":"5358_CR21","first-page":"88","volume":"50","author":"B Ehsani-Moghaddam","year":"2019","unstructured":"Ehsani-Moghaddam B, Martin K, Queenan JA. Data quality in healthcare: a report of practical experience with the Canadian primary care sentinel surveillance network data. Health Inf Manag. 2019;50:88\u201392.","journal-title":"Health Inf Manag"},{"key":"5358_CR22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/1475-2875-7-148","volume":"7","author":"M Karyana","year":"2008","unstructured":"Karyana M, Burdarm L, Yeung S, Kenangalem E, Wariker N, Maristela R, et al. Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum. Malar J. 2008;7:148.","journal-title":"Malar J"},{"key":"5358_CR23","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1007\/s00436-022-07512-9","volume":"121","author":"OO Oyegoke","year":"2022","unstructured":"Oyegoke OO, Maharaj L, Akoniyon OP, Kwoji I, Roux AT, Adewumi TS, et al. Malaria diagnostic methods with the elimination goal in view. Parasitol Res. 2022;121:1867\u201385.","journal-title":"Parasitol Res"},{"key":"5358_CR24","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1186\/s12913-019-4482-6","volume":"19","author":"SV Knudsen","year":"2019","unstructured":"Knudsen SV, Laursen HVB, Johnsen SP, Bartels PD, Ehlers LH, Mainz J. Can quality improvement improve the quality of care? A systematic review of reported effects and methodological rigor in plan-do-study-act projects. BMC Health Serv Res. 2019;19:683.","journal-title":"BMC Health Serv Res"},{"key":"5358_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13012-020-0978-z","volume":"15","author":"K Zamboni","year":"2020","unstructured":"Zamboni K, Baker U, Tyagi M, Schellenberg J, Hill Z, Hanson C. How and under what circumstances do quality improvement collaboratives lead to better outcomes? A Syst Rev Implement Sci. 2020;15:27.","journal-title":"A Syst Rev Implement Sci"},{"key":"5358_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2023-002522","volume":"13","author":"J Gagnon","year":"2024","unstructured":"Gagnon J, Breton M, Gaboury I. Decision-maker roles in healthcare quality improvement projects: a scoping review. BMJ Open Qual. 2024;13: e002522.","journal-title":"BMJ Open Qual"},{"key":"5358_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13012-020-0975-2","volume":"15","author":"JE Hill","year":"2020","unstructured":"Hill JE, Stephani A-M, Sapple P, Clegg AJ. The effectiveness of continuous quality improvement for developing professional practice and improving health care outcomes: a systematic review. Implement Sci. 2020;15:23.","journal-title":"Implement Sci"},{"issue":"2","key":"5358_CR28","first-page":"77","volume":"3","author":"FE Siagian","year":"2020","unstructured":"Siagian FE. Malaria epidemiology: specific vulnerable group in the population. Int J Res Rep Hematol. 2020;3(2):77\u201388.","journal-title":"Int J Res Rep Hematol"},{"key":"5358_CR29","first-page":"572","volume":"103","author":"JR Gutman","year":"2020","unstructured":"Gutman JR, Lucchi NW, Cantey PT, Steinhardt LC, Samuels AM, Kamb ML, et al. Malaria and parasitic neglected tropical diseases: potential syndemics with COVID-19? Am J Trop Med Hyg. 2020;103:572\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"5358_CR30","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S0140-6736(19)31096-7","volume":"394","author":"KE Battle","year":"2019","unstructured":"Battle KE, Lucas TCD, Nguyen M, Howes RE, Nandi AK, Twohig KA, et al. Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000\u201317: a spatial and temporal modelling study. Lancet. 2019;394:332\u201343.","journal-title":"Lancet"},{"key":"5358_CR31","unstructured":"WHO. World malaria report 2019. Geneva: World Health Organization; 2019. https:\/\/iris.who.int\/handle\/10665\/330011. Accessed 16 Nov 2024."},{"key":"5358_CR32","volume":"10","author":"MA Oboh","year":"2020","unstructured":"Oboh MA, Oyebola KM, Idowu ET, Badiane AS, Otubanjo OA, Ndiaye D. Rising report of Plasmodium vivax in sub-Saharan Africa: implications for malaria elimination agenda. Sci Afr. 2020;10: e00596.","journal-title":"Sci Afr"},{"key":"5358_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.parint.2021.102526","volume":"87","author":"F Angrisano","year":"2022","unstructured":"Angrisano F, Robinson LJ. Plasmodium vivax \u2013 How hidden reservoirs hinder global malaria elimination. Parasitol Int. 2022;87: 102526.","journal-title":"Parasitol Int"},{"key":"5358_CR34","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.omtm.2022.07.016","volume":"26","author":"EL Flannery","year":"2022","unstructured":"Flannery EL, Kangwanrangsan N, Chuenchob V, Roobsoong W, Fishbaugher M, Zhou K, et al. Plasmodium vivax latent liver infection is characterized by persistent hypnozoites, hypnozoite-derived schizonts, and time-dependent efficacy of primaquine. Mol Ther Method Clin Dev. 2022;26:427\u201340.","journal-title":"Mol Ther Method Clin Dev"},{"key":"5358_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002379","volume":"14","author":"NM Douglas","year":"2017","unstructured":"Douglas NM, Poespoprodjo JR, Patriani D, Malloy MJ, Kenangalem E, Sugiarto P, et al. Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: a hospital-based cohort study. PLoS Med. 2017;14: e1002379.","journal-title":"PLoS Med"},{"key":"5358_CR36","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12936-017-1784-1","volume":"16","author":"K Thriemer","year":"2017","unstructured":"Thriemer K, Ley B, Bobogare A, Dysoley L, Alam MS, Pasaribu AP, et al. Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group. Malar J. 2017;16:141.","journal-title":"Malar J"},{"key":"5358_CR37","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S1473-3099(23)00430-9","volume":"24","author":"RJ Commons","year":"2024","unstructured":"Commons RJ, Rajasekhar M, Edler P, Abreha T, Awab GR, Baird JK, et al. Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis. Lancet Infect Dis. 2024;24:172\u201383.","journal-title":"Lancet Infect Dis"},{"key":"5358_CR38","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1056\/NEJMoa2104226","volume":"386","author":"NN Chamma-Siqueira","year":"2022","unstructured":"Chamma-Siqueira NN, Negreiros SC, Ballard SB, Farias S, Silva SP, Chenet SM, et al. Higher-dose primaquine to prevent relapse of Plasmodium vivax malaria. N Engl J Med. 2022;386:1244\u201353.","journal-title":"N Engl J Med"},{"key":"5358_CR39","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12936-021-03869-x","volume":"20","author":"A de Pina-Costa","year":"2021","unstructured":"de Pina-Costa A, Silvino ACR, dos Santos EM, Pedro RS, Moreira J, Umana GL, et al. Increased primaquine total dose prevents Plasmodium vivax relapses in patients with impaired CYP2D6 activity: report of three cases. Malar J. 2021;20:341.","journal-title":"Malar J"},{"key":"5358_CR40","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40121-022-00713-w","volume":"12","author":"M Drysdale","year":"2023","unstructured":"Drysdale M, Tan L, Martin A, Fuhrer IB, Duparc S, Sharma H. Plasmodium vivax in children: hidden burden and conspicuous challenges, a narrative review. Infect Dis Ther. 2023;12:33\u201351.","journal-title":"Infect Dis Ther"},{"key":"5358_CR41","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/S2352-4642(24)00210-4","volume":"8","author":"RJ Commons","year":"2024","unstructured":"Commons RJ, Rajasekhar M, Allen EN, Yilma D, Chotsiri P, Abreha T, et al. Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15\u00a0years: a systematic review and individual patient data meta-analysis. Lancet Child Adolesc Health. 2024;8:798\u2013808.","journal-title":"Lancet Child Adolesc Health"},{"key":"5358_CR42","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S2352-4642(20)30127-9","volume":"4","author":"EA Ashley","year":"2020","unstructured":"Ashley EA, Poespoprodjo JR. Treatment and prevention of malaria in children. Lancet Child Adolesc Health. 2020;4:775\u201389.","journal-title":"Lancet Child Adolesc Health"},{"key":"5358_CR43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/tropicalmed8010067","volume":"8","author":"L Gao","year":"2023","unstructured":"Gao L, Shi Q, Liu Z, Li Z, Dong X. Impact of the COVID-19 pandemic on malaria control in Africa: a preliminary analysis. Trop Med Infect Dis. 2023;8:67.","journal-title":"Trop Med Infect Dis"},{"key":"5358_CR44","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.pt.2007.11.008","volume":"24","author":"KI Barnes","year":"2008","unstructured":"Barnes KI, Watkins WM, White NJ. Antimalarial dosing regimens and drug resistance. Trends Parasitol. 2008;24:127\u201334.","journal-title":"Trends Parasitol"},{"key":"5358_CR45","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/1475-2875-8-253","volume":"8","author":"NJ White","year":"2009","unstructured":"White NJ, Pongtavornpinyo W, Maude RJ, Saralamba S, Aguas R, Stepniewska K, et al. Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance. Malar J. 2009;8:253.","journal-title":"Malar J"},{"key":"5358_CR46","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/1475-2875-13-418","volume":"13","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Recht J, White NJ. Primaquine: the risks and the benefits. Malar J. 2014;13:418.","journal-title":"Malar J"},{"key":"5358_CR47","first-page":"2","volume":"1","author":"EPK Ameade","year":"2018","unstructured":"Ameade EPK, Tee CG, Dakurah HC, Opata HM. Uncomplicated malaria in children under 6\u00a0months or less than 5\u00a0Kg; how prescribers in Ghana manage it in the absence of a national policy. Int J Trop Med. 2018;1:2.","journal-title":"Int J Trop Med"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05358-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05358-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05358-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T09:05:40Z","timestamp":1749114340000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05358-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5358"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05358-x","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics committee of Menzies School of Health Research, Darwin, Australia (Ethical Clearance: HREC 2019 -\u20093368) and Gadjah Mada University, Yogyakarta, Indonesia (Ethical Clearance: KE\/FK\/1186\/EC\/2019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"177"}}